|
US2319808A
(en)
|
1939-08-31 |
1943-05-25 |
Squibb & Sons Inc |
Sterol derivatives and process for producing same
|
|
DE2417763A1
(de)
|
1974-04-11 |
1975-10-30 |
Bayer Ag |
Carbonsaeureamide, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
|
|
US4992417A
(en)
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogues
|
|
US4992418A
(en)
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
|
|
JPH01203351A
(ja)
|
1988-02-05 |
1989-08-16 |
Mitsui Petrochem Ind Ltd |
１，４−ジヒドロキシナフタレン誘導体および医薬
|
|
JPH023351A
(ja)
|
1988-06-16 |
1990-01-08 |
Oki Electric Ind Co Ltd |
印刷装置
|
|
US4861891A
(en)
|
1988-08-31 |
1989-08-29 |
Pfizer Inc. |
Antidepressant N-substituted nicotinamide compounds
|
|
US5514646A
(en)
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
|
JPH03184973A
(ja)
|
1989-12-14 |
1991-08-12 |
Rooman Kogyo:Kk |
放射線障害防護剤
|
|
US5260323A
(en)
*
|
1990-06-28 |
1993-11-09 |
Hoechst Aktiengesellschaft |
2,4- and 2,5-substituted pyridine-N-oxides, processes for their preparation and their use
|
|
TW197439B
(enExample)
|
1991-04-04 |
1993-01-01 |
Ueno Pharmaceutics Applic Res Co Ltd |
|
|
US5283253A
(en)
|
1991-09-23 |
1994-02-01 |
Florida State University |
Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
|
|
DE4201047A1
(de)
|
1992-01-17 |
1993-07-22 |
Bayer Ag |
Substituierte isoxazolcarbonsaeureamide
|
|
US5272137A
(en)
|
1992-02-14 |
1993-12-21 |
Mcneil-Pfc, Inc. |
Aqueous pharmaceutical suspension for pharmaceutical actives
|
|
US5200534A
(en)
|
1992-03-13 |
1993-04-06 |
University Of Florida |
Process for the preparation of taxol and 10-deacetyltaxol
|
|
US5294637A
(en)
|
1992-07-01 |
1994-03-15 |
Bristol-Myers Squibb Company |
Fluoro taxols
|
|
JP2994182B2
(ja)
|
1992-07-23 |
1999-12-27 |
石原産業株式会社 |
アミド系化合物又はその塩、それらの製造方法及びそれらを含有する有害動物防除剤
|
|
US5202448A
(en)
|
1992-08-14 |
1993-04-13 |
Napro Biotherapeutics, Inc. |
Processes of converting taxanes into baccatin III
|
|
US5415869A
(en)
|
1993-11-12 |
1995-05-16 |
The Research Foundation Of State University Of New York |
Taxol formulation
|
|
US5504188A
(en)
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
|
US5474978A
(en)
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5461031A
(en)
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
|
US5547929A
(en)
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
|
US5693609A
(en)
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
|
JP3833281B2
(ja)
*
|
1995-02-03 |
2006-10-11 |
日本曹達株式会社 |
２，６−ジクロロイソニコチン酸ベンジルアミド誘導体及び植物病害防除剤
|
|
AR002976A1
(es)
|
1995-03-31 |
1998-05-27 |
Lilly Co Eli |
Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
|
|
PT1019385E
(pt)
|
1995-09-15 |
2004-06-30 |
Upjohn Co |
N-oxidos de aminoaril-oxazolidinona
|
|
US6072050A
(en)
|
1996-06-11 |
2000-06-06 |
Pioneer Hi-Bred International, Inc. |
Synthetic promoters
|
|
FR2751645B1
(fr)
|
1996-07-29 |
1998-12-24 |
Sanofi Sa |
Amines pour la fabrication de medicaments destines a empecher la proliferation de cellules tumorales
|
|
ZA984697B
(en)
|
1997-06-13 |
1999-12-01 |
Lilly Co Eli |
Stable insulin formulations.
|
|
NZ503407A
(en)
*
|
1997-10-31 |
2002-08-28 |
Aventis Pharma Ltd |
Anilide derivatives useful for treating inflammatory diseases
|
|
US6121471A
(en)
|
1997-12-22 |
2000-09-19 |
Eli Lilly And Company |
Catalyst and method for amide formation
|
|
WO1999054284A1
(en)
|
1998-04-20 |
1999-10-28 |
Fujisawa Pharmaceutical Co., Ltd. |
Anthranilic acid derivatives as inhibitors of the cgmp-phosphodiesterase
|
|
AR019190A1
(es)
*
|
1998-07-08 |
2001-12-26 |
Sod Conseils Rech Applic |
Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
|
|
US6780883B2
(en)
*
|
1998-11-05 |
2004-08-24 |
Warner-Lambert Company |
Amide inhibitors of microsomal triglyceride transfer protein
|
|
US6900338B1
(en)
|
1998-11-25 |
2005-05-31 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Scavenger compounds
|
|
GB9919558D0
(en)
|
1999-08-18 |
1999-10-20 |
Hoechst Schering Agrevo Gmbh |
Fungicidal compounds
|
|
AU1466001A
(en)
|
1999-11-05 |
2001-05-14 |
Phase-1 Molecular Toxicology |
Methods of determining individual hypersensitivity to an agent
|
|
US20020034783A1
(en)
|
2000-04-18 |
2002-03-21 |
Rachel Meyers |
39228, a novel human alcohol dehydrogenase and uses therefor
|
|
EP1351946A2
(en)
|
2000-09-01 |
2003-10-15 |
Icos Corporation |
Materials and methods to potentiate cancer treatment
|
|
US6864265B2
(en)
*
|
2000-09-15 |
2005-03-08 |
Anormed, Inc. |
Chemokine receptor binding heterocyclic compounds
|
|
MXPA03002325A
(es)
*
|
2000-09-15 |
2003-06-24 |
Anormed Inc |
Compuestos heterociclicos que se unen a receptor de quimiocina.
|
|
WO2002053544A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Darwin Discovery Ltd. |
Pharmaceutical uses and synthesis of nicotinanilide-n-oxides
|
|
DOP2002000332A
(es)
*
|
2001-02-14 |
2002-08-30 |
Warner Lambert Co |
Inhibidores de piridina de metaloproteinasas de la matriz
|
|
US6678516B2
(en)
|
2001-05-21 |
2004-01-13 |
Nokia Corporation |
Method, system, and apparatus for providing services in a privacy enabled mobile and Ubicom environment
|
|
JP4448902B2
(ja)
|
2001-06-08 |
2010-04-14 |
株式会社医薬分子設計研究所 |
スルホンアミド誘導体
|
|
EP1438973A4
(en)
|
2001-10-05 |
2005-07-13 |
Ono Pharmaceutical Co |
MEANS FOR THE TREATMENT OF STRESS-RELATED DISEASES WITH MITOCHONDRIENE BENZODIAZEPINE RECEPTOR ANTAGONISTS
|
|
DE10149674A1
(de)
|
2001-10-09 |
2003-04-24 |
Apogepha Arzneimittel Gmbh |
Orale Darreichungsformen für Propiverin oder seinen pharmazeutisch annehmbaren Salzen mit verlängerter Wirkstoffreisetzung
|
|
US20030100034A1
(en)
*
|
2001-10-16 |
2003-05-29 |
Millennium Pharmaceuticals, Inc. |
9136, a human aldehyde dehydrogenase family member and uses therefor
|
|
PY0300568A
(es)
|
2002-01-31 |
2004-10-01 |
Pfizer Prod Inc |
Metabolitos del acido(3-{[4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi)acetico
|
|
EP2130820A1
(en)
|
2002-02-19 |
2009-12-09 |
Shionogi & Co., Ltd. |
Antipruritics
|
|
AU2003231370A1
(en)
|
2002-04-18 |
2003-10-27 |
Institute Of Medicinal Molecular Design. Inc. |
Amide derivatives
|
|
GB0215650D0
(en)
|
2002-07-05 |
2002-08-14 |
Cyclacel Ltd |
Bisarylsufonamide compounds
|
|
NZ538625A
(en)
*
|
2002-09-06 |
2008-05-30 |
Pharmacia & Upjohn Co Llc |
1,3-Diamino-2-hydroxypropane prodrug derivatives
|
|
EP1402888A1
(en)
|
2002-09-18 |
2004-03-31 |
Jerini AG |
The use of substituted carbocyclic compounds as rotamases inhibitors
|
|
EP1402887A1
(en)
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
|
US7135575B2
(en)
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
|
US7022850B2
(en)
|
2003-05-22 |
2006-04-04 |
Bristol-Myers Squibb Co. |
Bicyclicpyrimidones and their use to treat diseases
|
|
JP4359754B2
(ja)
*
|
2003-07-03 |
2009-11-04 |
三菱瓦斯化学株式会社 |
基板の洗浄剤
|
|
JP2007528717A
(ja)
|
2003-07-21 |
2007-10-18 |
オンコセラピー・サイエンス株式会社 |
結腸直腸癌を診断する方法
|
|
WO2005011561A2
(en)
|
2003-08-04 |
2005-02-10 |
Labcoat, Ltd. |
Stent coating apparatus and method
|
|
GB0318814D0
(en)
|
2003-08-11 |
2003-09-10 |
Smithkline Beecham Corp |
Novel compounds
|
|
EP1661572A1
(en)
|
2003-08-18 |
2006-05-31 |
Shionogi & Co., Ltd. |
Novel use of cannabinoid receptor agonist
|
|
FR2861071B1
(fr)
|
2003-10-17 |
2006-01-06 |
Sanofi Synthelabo |
Derives de n-[phenyl(alkylpiperidin-2-yl) methyl]benzamide, leur prepartation et leur application en therapeutique
|
|
FR2861074B1
(fr)
|
2003-10-17 |
2006-04-07 |
Sanofi Synthelabo |
Derives de n-[phenyl(piperidin-2-yl)methyl]benzamide, leur preparation et leur application en therapeutique
|
|
EP1702213A4
(en)
|
2003-12-09 |
2007-07-18 |
Univ Leland Stanford Junior |
METHOD AND COMPOSITIONS FOR MODULATING MITOCHONDRIAL ALDEHYDE DEHYDROGENASE-2
|
|
WO2005070889A1
(en)
*
|
2004-01-23 |
2005-08-04 |
E.I. Dupont De Nemours And Company |
Herbicidal amides
|
|
TW200534852A
(en)
|
2004-03-03 |
2005-11-01 |
Convivia |
4-methylpyrazole formulations for inhibiting ethanol intolerance
|
|
CA2567223A1
(en)
|
2004-05-19 |
2005-11-24 |
Boehringer Ingelheim International Gmbh |
Treatment of diseases associated with altered level of amyloid beta peptides
|
|
CN1749415A
(zh)
|
2004-09-15 |
2006-03-22 |
上海人类基因组研究中心 |
硝酸甘油治疗急性心绞痛疗效检测方法和试剂盒
|
|
ES2377758T3
(es)
*
|
2004-11-12 |
2012-03-30 |
Bristol-Myers Squibb Company |
Compuestos tricíclicos basados en tiazolo[4,5-b]piridina imidazo-fusionada y composiciones farmacéuticas que los comprenden
|
|
US7888374B2
(en)
*
|
2005-01-28 |
2011-02-15 |
Abbott Laboratories |
Inhibitors of c-jun N-terminal kinases
|
|
DOP2006000051A
(es)
|
2005-02-24 |
2006-08-31 |
Lilly Co Eli |
Inhibidores de vegf-r2 y métodos
|
|
ES2340200T3
(es)
|
2005-09-23 |
2010-05-31 |
Pfizer Products Inc. |
Benzamidas sustituidas con piridinaminosulfonil como inhibidores de citromo p450 3a4 (cyp3a4).
|
|
EP1963273A2
(en)
|
2005-12-22 |
2008-09-03 |
Wyeth a Corporation of the State of Delaware |
Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitors
|
|
US20100261758A1
(en)
|
2006-03-28 |
2010-10-14 |
Novartis Ag |
Heterocyclic amides for use as pharmaceuticals
|
|
EP2727585A1
(en)
|
2006-05-16 |
2014-05-07 |
Takeda Pharmaceutical Company Limited |
In-vivo screening method
|
|
WO2007136707A2
(en)
|
2006-05-17 |
2007-11-29 |
University Of Utah Research Foundation |
Methods and compositions related to eosinophil regulation
|
|
US20080003585A1
(en)
|
2006-06-29 |
2008-01-03 |
Bio-Rad Laboratories, Inc., A Corporation Of The State Of Delaware |
Purification and amplification of nucleic acids in a microfluidic device
|
|
CA2653056A1
(en)
|
2006-07-27 |
2008-01-31 |
Cv Therapeutics, Inc. |
Aldh-2 inhibitors in the treatment of addiction
|
|
PE20080906A1
(es)
|
2006-08-17 |
2008-07-05 |
Kemia Inc |
Derivados heteroarilo como inhibidores de citocina
|
|
EP2064187A2
(en)
|
2006-08-25 |
2009-06-03 |
Vitae Pharmaceuticals, Inc. |
Inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
|
|
ATE507205T1
(de)
*
|
2006-12-11 |
2011-05-15 |
Genetics Co Inc |
Aromatische 1,4-di-carboxylamide und deren verwendung
|
|
WO2008082490A2
(en)
|
2006-12-20 |
2008-07-10 |
Schering Corporation |
Novel jnk inhibitors
|
|
CA2672940A1
(en)
*
|
2006-12-20 |
2008-07-10 |
Schering Corporation |
Novel jnk inhibitors
|
|
WO2008103354A2
(en)
|
2007-02-20 |
2008-08-28 |
Cropsolution, Inc. |
Modulators of acetyl-coenzyme a carboxylase and methods of use thereof
|
|
WO2008112164A2
(en)
|
2007-03-08 |
2008-09-18 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
|
US8642660B2
(en)
|
2007-12-21 |
2014-02-04 |
The University Of Rochester |
Method for altering the lifespan of eukaryotic organisms
|
|
US8124389B2
(en)
|
2008-05-07 |
2012-02-28 |
The Board Of Trustees Of The Leland Stanford Junior University |
Crystal structure of aldehyde dehydrogenase and methods of use thereof
|
|
CN102112447B
(zh)
*
|
2008-06-04 |
2013-06-26 |
阿姆布里利亚生物制药公司 |
来自吡哆醇的hiv整合酶抑制剂
|
|
MX2010014572A
(es)
|
2008-06-27 |
2011-03-24 |
Novartis Ag |
Compuestos organicos.
|
|
EP2337563B1
(en)
|
2008-09-08 |
2014-04-09 |
The Board of Trustees of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase activity and methods of use thereof
|
|
JP2012506856A
(ja)
|
2008-10-28 |
2012-03-22 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
アルデヒドデヒドロゲナーゼのモジュレーターおよびその使用方法
|
|
CN105254557A
(zh)
|
2009-05-29 |
2016-01-20 |
拉夸里亚创药株式会社 |
作为钙或钠通道阻滞剂的芳基取代羧酰胺衍生物
|
|
US8552200B2
(en)
|
2010-10-20 |
2013-10-08 |
Gruenenthal Gmbh |
Substituted 6-amino-nicotinamides as KCNQ2/3 modulators
|
|
WO2012082862A2
(en)
|
2010-12-14 |
2012-06-21 |
Beth Israel Deaconess Medical Center |
Androgen receptor inhibitors and methods of use thereof
|
|
WO2012106534A2
(en)
|
2011-02-02 |
2012-08-09 |
The Regents Of The University Of California |
Hiv integrase inhibitors
|
|
WO2012149106A1
(en)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
|
EP2751093A1
(en)
|
2011-08-29 |
2014-07-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|